2026 Q2 Portfolio Activity
In 2026 Q2, ACORN CAPITAL ADVISORS, LLC maintained a portfolio of 23 distinct positions. They heavily accumulated shares in KARYOPHARM THERAPEUTICS INC, increasing the position by 427.4%. Conversely, ACORN CAPITAL ADVISORS, LLC completely exited their position in TERNS PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Total Positions
23
Quarter
2026 Q2
Top Holding
CGON (21.9%)
Top 10 Concentration
90.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-23 of 23
ACORN CAPITAL ADVISORS, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CGON
CG ONCOLOGY INC
|
Healthcare | 21.94% | 21.77% |
#1
1
Prev: #2
|
6.5 |
—
|
999 | 0.1% |
P
S
|
1,131,500 | $80,393,115 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 16.80% | 8.55% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
1,673,420 | $61,581,856 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 10.92% | 7.27% |
#3
2
Prev: #5
|
6.0 |
—
|
no change | no change |
P
S
|
2,144,844 | $40,001,341 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CADL
CANDEL THERAPEU...
|
Healthcare | 9.83% | 4.89% |
#4
2
Prev: #6
|
5.4 |
—
|
no change | no change |
P
S
|
3,497,948 | $36,028,864 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PBYI
PUMA BIOTECHNOL...
|
Healthcare | 9.14% | 7.50% |
#5
1
Prev: #4
|
5.2 |
—
|
no change | no change |
P
S
|
4,131,299 | $33,504,835 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JBIO
JADE BIOSCEINCE...
|
Healthcare | 5.98% | 3.14% |
#6
3
Prev: #9
|
4.9 |
—
|
200,000 | 25.4% |
P
S
|
986,760 | $21,925,807 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 5.21% | 3.64% |
#7
Prev: #7
|
2.6 |
—
|
-1 | -0.0% |
P
S
|
643,381 | $19,102,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 4.05% | 0.46% |
#8
10
Prev: #18
|
4.6 |
—
|
1,230,287 | 427.4% |
P
S
|
1,518,113 | $14,831,964 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OKUR
ONKURE THERAPEU...
|
Healthcare | 3.53% | 3.34% |
#9
1
Prev: #8
|
2.4 |
—
|
no change | no change |
P
S
|
2,839,674 | $12,948,913 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYBN
HELUS PHARMA IN...
|
Unknown | 2.78% | 2.10% |
#10
2
Prev: #12
|
2.1 |
—
|
no change | no change |
P
S
|
1,540,266 | $10,181,159 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 1.83% | 2.59% |
#11
1
Prev: #10
|
1.7 |
—
|
no change | no change |
P
S
|
1,752,115 | $6,693,079 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 1.80% | 1.13% |
#12
2
Prev: #14
|
3.7 |
—
|
333,333 | 56.0% |
P
S
|
929,077 | $6,596,447 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LONA
LEONABIO, INC.
|
Healthcare | 1.59% | 1.85% |
#13
Prev: #13
|
1.6 |
—
|
no change | no change |
P
S
|
634,539 | $5,831,413 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 1.53% | 2.21% |
#14
3
Prev: #11
|
1.6 |
—
|
no change | no change |
P
S
|
1,469,153 | $5,612,164 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 1.42% | 1.12% |
#15
Prev: #15
|
1.6 |
—
|
no change | no change |
P
S
|
1,139,363 | $5,218,283 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QTTB
Q32 BIO INC.
|
Healthcare | 0.75% | 0.57% |
#16
1
Prev: #17
|
0.3 |
—
|
-98,881 | -31.4% |
P
S
|
216,171 | $2,754,019 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
EUGENE THERAPEU...
|
|
Unknown | 0.60% | — |
#17
Prev: #—
|
3.7 |
—
|
1,271,257 | — |
NEW
|
1,271,257 | $2,199,275 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
JSPR
JASPER THERAPEU...
|
Healthcare | 0.16% | 0.35% |
#18
1
Prev: #19
|
0.6 |
—
|
26,667 | 1.9% |
P
S
|
1,438,159 | $604,027 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCAB
BIOATLA INC
|
Healthcare | 0.12% | 0.25% |
#19
2
Prev: #21
|
0.0 |
—
|
-5,298,219 | -98.0% |
P
S
|
108,126 | $447,645 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VYNE
VYNE THERAPEUTI...
|
Healthcare | 0.00% | 0.00% |
#20
2
Prev: #22
|
1.0 |
—
|
no change | no change |
P
S
|
1,425 | $926 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
X4 PHARMACEUTIC...
|
|
Unknown | 0.00% | 0.27% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-234,039 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
CRDF
CARDIF ONCOLOGY...
|
Healthcare | 0.00% | 0.81% |
Sold All 😨
(Was: #16) |
0.0 |
—
|
-1,762,084 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 0.00% | 26.17% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-1,746,264 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-23 of 23 holdings